Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DZZN | ISIN: US2214133058 | Ticker-Symbol: V67A
Frankfurt
17.04.25
08:03 Uhr
0,302 Euro
+0,003
+0,87 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
COSMOS HEALTH INC Chart 1 Jahr
5-Tage-Chart
COSMOS HEALTH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2870,30017.04.

Aktuelle News zur COSMOS HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCosmos Health Inc.: Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million216CHICAGO, April 16, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
DiCosmos Health Inc. - 10-K, Annual Report1
09.04.Cosmos Health sichert Vertrag für Antiseptika-Produktion1
09.04.Cosmos Health secures deal for antiseptic drug production2
09.04.Cosmos Health Inc.: Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L338CHICAGO, April 09, 2025 ("Cosmos Health" or the "Company') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical...
► Artikel lesen
COSMOS HEALTH Aktie jetzt für 0€ handeln
08.04.Cosmos Health launches Sky Premium Life in Albania, secures $0.3M order1
08.04.Cosmos Health expands into Albania with new supplement brand4
08.04.Cosmos Health Inc.: Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order360CHICAGO, April 08, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
26.02.Cosmos Health Inc.: Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates467CHICAGO, IL / ACCESS Newswire / February 26, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
18.02.Cosmos Health Inc. - 8-K, Current Report-
18.02.Cosmos Health postpones securities offering5
18.02.Cosmos Health Inc.: Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1283CHICAGO, IL / ACCESS Newswire / February 18, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
12.02.Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents2
11.02.Cosmos Health advances weight management device to clinical trials4
11.02.Cosmos Health Inc.: Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market248Finalizing scale-up production phaseEngaging with Contract Research Organizations to complete the technical dossierClinical trials expected to complete in late 2025 or early 2026Potential classification...
► Artikel lesen
10.02.Cosmos Health meldet Patente für Krebsbehandlungen an1
10.02.Cosmos Health Inc.: Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market356CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
10.02.Cosmos Health Inc.: Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations223CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
07.02.Cosmos Health Inc. - S-1/A, General form for registration of securities-
07.02.Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals1
Seite:  Weiter >>
88 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1